Argenx said it reached an agreement to buy Forte Biosciences for $2.2 billion, moving to strengthen its immunology pipeline. European pharmaceutical company Argenx is acquiring Nasdaq-listed Forte for ...

Dow Jones Top Financial Services Headlines at 12 AM ET: Federal Probe into Dodgers Owner's Financial Empire Was Sparked By Whistleblower | Singapore ...

Rising Treasury yields show how 'enormously worried' the market is about inflation - and whether the Fed will back up its tough talk with action Federal Reserve Chair Kevin Warsh may need to raise ...

The hottest tech trades of 2026 just got slammed - smart investors are buying anyway Chip stocks have taken a beating - but there's reason to stay bullish. A bull market supported by several sectors ...

Will FRIFX outperform in the future? Get our overall rating based on a fundamental assessment of the pillars below.

Will FNMIX outperform in the future? Get our overall rating based on a fundamental assessment of the pillars below.

For more than 40 years, investors have trusted Morningstar to tell it like it is. Our independent analysis and investment research tools uncover how well an investment serves investors—and no one else ...

"It's looking like I'll be unemployed for longer than six months." Dear Dollar Signs, I lost my job about four months ago and still haven't found anything. My rent also went up by $500, meaning I'll ...

Will FCNVX outperform in the future? Get our overall rating based on a fundamental assessment of the pillars below.

Will FBNDX outperform in the future? Get our overall rating based on a fundamental assessment of the pillars below.

This article mentions funds that have an issuer-initiated rating and/or track a Morningstar Index. For full disclosure information, please refer to the specific funds, which are demarcated with a * ...

Cardholder perks are resonating, an executive says. 'It's really about access.' Amex recently conducted a refresh of its Platinum card. American Express customers just registered their highest ...